Vaishali Pharma Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 323.96 million compared to INR 262.38 million a year ago. Revenue was INR 333.01 million compared to INR 267.67 million a year ago. Net loss was INR 46.83 million compared to net income of INR 4.36 million a year ago. Basic loss per share from continuing operations was INR 4.37 compared to basic earnings per share from continuing operations of INR 0.41 a year ago. Diluted loss per share from continuing operations was INR 4.17 compared to diluted earnings per share from continuing operations of INR 0.06 a year ago.
For the full year, sales was INR 862.8 million compared to INR 696.63 million a year ago. Revenue was INR 883.13 million compared to INR 718.92 million a year ago. Net income was INR 7.19 million compared to INR 66.03 million a year ago. Basic earnings per share from continuing operations was INR 0.67 compared to INR 6.26 a year ago. Diluted earnings per share from continuing operations was INR 0.64 compared to INR 5.91 a year ago.